Raymond James Downgrades Exro Technologies to Outperform, Lowers Price Target to C$2.75
Raymond James downgrades Exro Technologies (TSX:EXRO) from Strong Buy to Outperform and lowers the price target from C$4 to C$2.75.
Deutsche Bank Downgrades Ball to Hold, Lowers Price Target to $65
Deutsche Bank analyst Kyle White downgrades Ball (NYSE:BALL) from Buy to Hold and lowers the price target from $81 to $65.
HC Wainwright & Co. Downgrades ChemoCentryx to Neutral, Lowers Price Target to $52
HC Wainwright & Co. analyst Edward White downgrades ChemoCentryx (NASDAQ:CCXI) from Buy to Neutral and lowers the price target from $101 to $52.
Oppenheimer Downgrades BioCryst Pharmaceuticals to Perform
Oppenheimer analyst Justin Kim downgrades BioCryst Pharmaceuticals (NASDAQ:BCRX) from Outperform to Perform.
Atlantic Equities Downgrades Twilio to Neutral
Atlantic Equities analyst Peter Sazel downgrades Twilio (NYSE:TWLO) from Overweight to Neutral.
Stephens & Co. Downgrades Itron to Equal-Weight, Lowers Price Target to $55
Stephens & Co. analyst Tommy Moll downgrades Itron (NASDAQ:ITRI) from Overweight to Equal-Weight and lowers the price target from $65 to $55.
Susquehanna Downgrades Twitter to Neutral, Announces $45 Price Target
Susquehanna analyst Shyam Patil downgrades Twitter (NYSE:TWTR) from Positive to Neutral and announces $45 price target.
Jefferies Downgrades Compugen to Hold, Announces $2 Price Target
Jefferies analyst Chris Howerton downgrades Compugen (NASDAQ:CGEN) from Buy to Hold and announces $2 price target.
Deutsche Bank Downgrades Ingersoll Rand to Hold, Raises Price Target to $52
Deutsche Bank analyst Nicole Deblase downgrades Ingersoll Rand (NYSE:IR) from Buy to Hold and raises the price target from $50 to $52.
MKM Partners Downgrades Playtika Holding to Neutral, Lowers Price Target to $13.5
MKM Partners analyst Eric Handler downgrades Playtika Holding (NASDAQ:PLTK) from Buy to Neutral and lowers the price target from $17 to $13.5.